LOVELAND, Colo., Nov. 12, 2012 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today a new distribution agreement with MWI Veterinary Supply. MWI will inventory, market and promote the full line of Heska's veterinary products throughout the United States beginning January 2, 2013. Certain products, such as the popular Vet/IV Infusion Pump, will be available through MWI immediately.
"We believe this partnership represents a significant opportunity," says Robert Grieve, Chairman and Chief Executive Officer of Heska Corporation. "Improving the choices available for advanced diagnostic solutions will benefit both customers and the animal health industry as a whole, and improve business opportunities for both MWI and Heska."
"MWI is very pleased to offer our customers the additional solutions Heska's products provide. We look forward to working with Heska as we continue our shared missions of serving veterinary professionals," said Jim Cleary, MWI President and Chief Executive Officer.
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians. For further information on Heska and its products, visit the company's website at www.heska.com.
MWI is a leading distributor of animal health products across the United States and the United Kingdom. MWI sells both companion animal and production animal products including pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, supplies, pet food, capital equipment and technologies used by veterinarians and producers.
This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. There are uncertainties regarding Heska's ability to successfully commercialize new products; competition, including new products competitors may introduce in the future; uncertainties related to Heska's market estimates; uncertainties regarding Heska's ability to gain market share in an economic manner; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Quarterly Report on Form 10-Q for the quarter ended June 30, 2012.
SOURCE Heska Corporation